Tuesday, January 4, 2000
1999 M&A activity
The following 60 biotech mergers and acquisitions in 1999 have
an aggregate value of $19.1 billion, with an average size of $317.8 million.
The table excludes 13 mergers or acquisitions that did not include deal terms.
Also not included are pharma-to-pharma deals, CRO deals, reverse mergers, purchases
of portions of businesses, which include the purchase of an